Abbott Laboratories ( ABT) - Stock Earnings
ABT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 16, 2026 BeforeMarket | — / — | — | — / — | — |
ABT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 1.6 billion USD | 11.4 billion USD |
| 2025Q4 | 1.8 billion USD | 11.5 billion USD |
| 2026Q1 | 1.1 billion USD | 11.2 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ABT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.7 billion USD | 40.1 billion USD |
| 2024 | 13.4 billion USD | 42.0 billion USD |
| 2025 | 6.5 billion USD | 44.3 billion USD |
| 2026 Est. | — | — |
ABT
List: Contenders
Price: $91.79
Dividend Yield: 2.71%
Forward Dividend Yield: 2.78%
Payout Ratio: 69.40%
Dividend Per Share: 2.52 USD
Earnings Per Share: 3.57 USD
P/E Ratio: 25.69
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.1 million
Ebitda: 1.7 billionMarket Capitalization: 157.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 44
DGR3: 7.41%
DGR5: 10.99%
DGR10: 9.59%
DGR20: 4.31%